We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$140M
AUM Growth
+$712K
Cap. Flow
+$5.04M
Cap. Flow %
3.61%
Top 10 Hldgs %
97.21%
Holding
16
New
2
Increased
2
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$11M
2
EVAR
Lombard Medical, Inc.
EVAR
+$837K
3
TRIL
Trillium Therapeutics Inc.
TRIL
+$159K
4
RCKT icon
Rocket Pharmaceuticals
RCKT
+$85.6K

Top Sells

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$4.1M
2
DVAX
Dynavax Technologies
DVAX
+$1.05M
3
SAGE
Sage Therapeutics
SAGE
+$874K
4
DERM
Dermira, Inc.
DERM
+$519K
5
ADAP
Adaptimmune Therapeutics
ADAP
+$388K

Sector Composition

Rank Sector Weight
1 Healthcare 95.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAV
1
DELISTED
Aravive, Inc. Common Stock
ARAV
$30.4M 21.76%
339,871
– –
PDSB icon
2
PDS Biotechnology
PDSB
$38.1M
$29.3M 20.99%
117,243
– –
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$20.6M 14.75%
1,377,497
– –
WVE icon
4
Wave Life Sciences
WVE
$1.12B
$17.2M 12.33%
658,259
-125,900
-16% -$4.1M
CRSP icon
5
CRISPR Therapeutics
CRSP
$4.58B
$11.9M 8.51%
+586,475
New +$11M
DMTX
6
DELISTED
Dimension Therapeutics, Inc
DMTX
$8.96M 6.42%
2,059,283
– –
SAGE
7
DELISTED
Sage Therapeutics
SAGE
$5.83M 4.17%
114,123
-18,551
-14% -$874K
DERM
8
DELISTED
Dermira, Inc.
DERM
$5.39M 3.86%
177,844
-16,100
-8% -$519K
ALDR
9
DELISTED
Alder Biopharmaceuticals
ALDR
$4.75M 3.4%
228,428
-2,526
-1% -$65.7K
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.4M 1%
259,067
– –
VTGN icon
11
VistaGen Therapeutics
VTGN
$9.29M
$1.32M 0.94%
11,765
– –
DVAX
12
DELISTED
Dynavax Technologies
DVAX
$1.01M 0.73%
256,381
-144,000
-36% -$1.05M
EVAR
13
DELISTED
Lombard Medical, Inc.
EVAR
$643K 0.46%
+1,072,634
New +$837K
TRIL
14
DELISTED
Trillium Therapeutics Inc.
TRIL
$547K 0.39%
96,759
+16,000
+20% +$159K
RCKT icon
15
Rocket Pharmaceuticals
RCKT
$348M
$380K 0.27%
15,575
+3,000
+24% +$85.6K
ADAP
16
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-55,008
Closed -$388K

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q4 2016 Portfolio in Review

As of Q4 2016, New Leaf Venture Partners held 16 positions worth $140M, up 0.51% from $139M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

New Leaf Venture Partners deployed $5.04M of net new capital in Q4 2016, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was CRISPR Therapeutics: 586,475 shares worth $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier.

On the sell side, the largest reduction was Wave Life Sciences, an estimated $4.1M trimmed.

  • New Leaf Venture Partners's largest Q4 2016 buy was CRISPR Therapeutics: 586,475 shares worth $11.9M.
  • New Leaf Venture Partners added most to Trillium Therapeutics Inc. in Q4 2016, an estimated $159K increase.
  • New Leaf Venture Partners's biggest Q4 2016 reduction was Wave Life Sciences, cutting an estimated $4.1M.
  • New Leaf Venture Partners fully exited Adaptimmune Therapeutics in Q4 2016, selling an estimated $388K.
  • New Leaf Venture Partners's ten largest holdings make up 97% of its $140M portfolio in Q4 2016.
  • New Leaf Venture Partners opened 2 new positions and closed 1 in Q4 2016.
  • New Leaf Venture Partners's portfolio value rose 0.51% quarter-over-quarter to $140M.

Based on New Leaf Venture Partners's 13F filing for Q4 2016, filed 14 Feb 2017.